Observationa Study is a Prospective and Multi-institutional Observational Study.

Jeil Pharmaceutical Co., Ltd.5,536 enrolled

Overview

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

The present observational study is designed to check effect and safety for patients who have been prescribed JAQBO for the treatment of erosive gastroesophageal reflux disease.

Study Type

OBSERVATIONAL

Enrollment

5,536

Conditions

Erosive Reflux Disease Heartburn Acid Regurgitation

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. An adult over 19 years of age 2. A person who voluntarily provides written informed consent Exclusion Criteria: 1. A pregnant woman or a nursing woman 2. A person who is deemed unsuitable for the subject of the study

Locations (1)

Goodbreath Medical Center

Seoul, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Change in GERD (heartburn, acid regurgitation) score in RDQ

Scale(none / 1day / 2day/ 3-4 day / 5-6 day/ every day)

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.